- Home
- TUSK vs ALDX Comparison
TUSK vs ALDX Comparison
Compare TUSK & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TUSK | ALDX |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.7M | 103.1M |
| IPO Year | 2016 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TUSK | ALDX |
|---|---|---|
| Price | $2.98 | $1.77 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.50 |
| AVG Volume (30 Days) | 330.1K | ★ 1.3M |
| Earning Date | 05-11-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 102.32 | 40.43 |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $44,292,000.00 | N/A |
| Revenue This Year | $383.90 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $23.64 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.72 | $1.07 |
| 52 Week High | $3.92 | $6.18 |
Technical Indicators
Market Signals| Indicator | TUSK | ALDX |
|---|---|---|
| Relative Strength Index (RSI) | 45.35 | 49.01 |
| Support Level | $2.18 | $1.49 |
| Resistance Level | $3.54 | $1.91 |
| Average True Range (ATR) | 0.23 | 0.16 |
| MACD | -0.07 | 0.01 |
| Stochastic Oscillator | 30.54 | 24.11 |
Price Performance
Historical ComparisonAbout TUSK Mammoth Energy Services Inc.
Mammoth Energy Services Inc is an integrated energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. The company had three reportable segments, which includes rental services, infrastructure services, natural sand proppant services, accommodation services, and drilling services.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.